FWIW, I think ORCT is headed much higher. It just got coverage from a second firm yesterday, CE Unterberg Towbin starting it at Buy with a target of $30. It also got initiated as a Buy by the Oberweiss newsletter. Today, it broke through the 50 day MA and it also broke the downtrend sind the earnings spike.
Longer term, the fundamentals point well above 30, so I'm holding all my ORCT through any spikes and pullbacks.
Market Data 
Markets 
AI
